Leverage our cross-border relationships to drive success in biosimilar development and commercialization.

We facilitate:

• Strategic partnerships with biosimilar manufacturers in South Korea and India
• Collaboration models with biotech firms, CROs, CDMOs, and clinical research partners
• Support for regulatory planning, licensing, and early-stage engagement
• Project coordination for US, Korean, and emerging biosimilar markets
• From early-stage development to market entry, Biovence offers the insight and network to accelerate your biologic pipeline.